CIK 0001396814
- Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 510619477
- Phone
- +1 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $217,920
- in 1 filing, $218K under 10b5-1 plans
Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-03 | WINSTON ROY Chief Medical Officer | Sale | −476 | $55.70 | $27K | 44,992 |
| 2022-08-03 | SLONIN JONATHAN Chief Clinical Officer | Sale | −308 | $55.70 | $17K | 37,079 |
| 2022-07-11 | HASTINGS PAUL J Director | Sale | −533 | $56.95 | $30K | 7,179 |
| 2022-07-05 | SLONIN JONATHAN Chief Clinical Officer | Sale | −924 | $57.19 | $53K | 37,387 |
| 2022-06-14 | LARANJEIRA CHARLES ANTHONY Chief Technical Officer | Option exercise | +6,000 | $38.35 | $230K | 41,752 |
| 2022-06-14 | LARANJEIRA CHARLES ANTHONY Chief Technical Officer | Option exercise · Stock Option (Right to Buy) | −6,000 | 9,000 | ||
| 2022-06-08 | STACK DAVID M CEO and Chairman | Sale | −7,039 | $59.10 | $416K | 149,040 |
| 2022-06-08 | STACK DAVID M CEO and Chairman | Sale | −5,006 | $60.33 | $302K | 144,034 |
| 2022-06-08 | STACK DAVID M CEO and Chairman | Sale | −1,282 | $61.31 | $79K | 142,752 |
| 2022-06-08 | STACK DAVID M CEO and Chairman | Sale | −501 | $61.96 | $31K | 142,251 |
| 2022-06-08 | STACK DAVID M CEO and Chairman | Grant or award | +21,500 | 163,751 | ||
| 2022-06-08 | STACK DAVID M CEO and Chairman | Grant or award · Stock Option (Right to Buy) | +160,900 | 160,900 | ||
| 2022-06-08 | WINSTON ROY Chief Medical Officer | Grant or award | +9,900 | 45,060 | ||
| 2022-06-08 | WINSTON ROY Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +24,800 | 24,800 | ||
| 2022-06-08 | Williams Kristen Marie Chief Administrative Officer | Grant or award | +9,900 | 23,550 | ||
| 2022-06-08 | Williams Kristen Marie Chief Administrative Officer | Grant or award · Stock Option (Right to Buy) | +24,800 | 24,800 | ||
| 2022-06-08 | SLONIN JONATHAN Chief Clinical Officer | Grant or award | +9,900 | 38,097 | ||
| 2022-06-08 | SLONIN JONATHAN Chief Clinical Officer | Sale · Stock Option (Right to Buy) | +24,800 | 24,800 | ||
| 2022-06-08 | Riker Lauren Bullaro Senior Vice President, Finance | Grant or award | +5,850 | 19,852 | ||
| 2022-06-08 | Riker Lauren Bullaro Senior Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +14,600 | 14,600 |
Page 13 of 23 · 450 trades